Have a personal or library account? Click to login
Metastatic Renal Cell Carcinoma: Sunitinib as First-Line Treatment; Results of a Retrospective Study Cover

Metastatic Renal Cell Carcinoma: Sunitinib as First-Line Treatment; Results of a Retrospective Study

Forum of Clinical Oncology
Volume 6 (2015): Issue 4 (December 2015)
By: Hend Ahmed El-Hadaad,  Hanan Ahmed Wahba and  Hayam Fathy Abd-El Hay Ghazy  
Open Access
|Mar 2016

Authors

Hend Ahmed El-Hadaad

hend_am@mans.edu.eg

Hanan Ahmed Wahba

Hayam Fathy Abd-El Hay Ghazy

DOI: https://doi.org/10.1515/fco-2015-0017 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 23 - 27
Submitted on: Aug 30, 2015
Accepted on: Dec 15, 2015
Published on: Mar 31, 2016
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Sunitinib,
Metastasis,
Renal Cell Carcinoma,
Targeted agents
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2016 Hend Ahmed El-Hadaad, Hanan Ahmed Wahba, Hayam Fathy Abd-El Hay Ghazy, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 6 (2015): Issue 4 (December 2015)Next article